Perrigo Company PLC (PRGO) is not a strong buy at the moment for a beginner investor with a long-term strategy. While there are some positive insider buying trends, the company's financial performance has been weak, with declining revenue and significant net income losses. Additionally, the stock's technical indicators and options data do not suggest a strong upward momentum. It is better to hold off on investing until there are clearer signs of recovery or growth.
The MACD is positive but contracting, indicating weakening bullish momentum. RSI is neutral at 60.838, showing no clear overbought or oversold condition. Moving averages are converging, suggesting indecision in price direction. Key support levels are at 10.701 and 10.293, while resistance levels are at 12.023 and 12.431. The stock is trading near its pivot level of 11.362, indicating a lack of strong directional movement.

Insiders are buying, with a 107.21% increase in buying activity over the last month. The company has reported share gains in private label store brands and key branded businesses despite challenges in the infant nutrition sector.
Revenue dropped by 2.52% YoY in Q4 2025, and net income remains significantly negative at -1.418 billion. Analysts have lowered price targets, citing challenges in the infant nutrition business. The stock has a 30% chance of declining by -8.19% in the next month based on similar candlestick patterns.
In Q4 2025, revenue declined by 2.52% YoY to $1.1096 billion. Net income increased significantly to -$1.418 billion, up 3086.74% YoY, but remains negative. EPS improved to -10.31, up 3121.88% YoY, but still negative. Gross margin dropped to 32.64%, down 3.72% YoY, reflecting weaker profitability.
JPMorgan lowered the price target from $18 to $15 and maintains a Neutral rating. Canaccord lowered the price target from $20 to $17 but maintains a Buy rating, citing challenges in the infant nutrition business but strength in other areas of the business.